As of 4:02pm ET
| +0.04 / +0.09%|
The 5 analysts offering 12-month price forecasts for WuXi PharmaTech (Cayman) Inc have a median target of 46.00, with a high estimate of 51.00 and a low estimate of 42.00. The median estimate represents a +4.19% increase from the last price of 44.15.
The current consensus among 7 polled investment analysts is to Hold stock in WuXi PharmaTech (Cayman) Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.